Cargando…
PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
BACKGROUND: Phosphoglucomutase (PGM), a key enzyme in the metabolism of glucose-1-phosphate and glucose-6-phosphate, has been found to be associated with proliferation, invasion, and metastasis of cancer. However, the expression and function of PGM5 in colorectal cancer (CRC) remains unknown. METHOD...
Autores principales: | Sun, Yifan, Long, Haihua, Sun, Lin, Sun, Xiujuan, Pang, Liping, Chen, Jianlin, Yi, Qingqun, Liang, Tianwei, Shen, Yongqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771116/ https://www.ncbi.nlm.nih.gov/pubmed/31582909 http://dx.doi.org/10.1186/s12935-019-0967-y |
Ejemplares similares
-
PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway
por: Zheng, Zhewen, et al.
Publicado: (2022) -
Six immune-related promising biomarkers may promote hepatocellular carcinoma prognosis: a bioinformatics analysis and experimental validation
por: Lin, Xia-Hui, et al.
Publicado: (2023) -
Knockdown of PGM1 enhances anticancer effects of orlistat in gastric cancer under glucose deprivation
por: Cao, Bo, et al.
Publicado: (2021) -
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
por: Chen, Jingxuan, et al.
Publicado: (2020) -
Meta-analysis of the effect of PGM on survival prognosis of tumor patients
por: Zheng, Zhewen, et al.
Publicado: (2022)